Shape Matters: Drug-free Glioblastoma Targeting with Magnetic Microparticles

Abstract Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options and poor survival rates. In this study, we investigate the potential of peanut-shaped and sphere-shaped microparticles as microrobots for targeted GBM therapy, specifically using the U87 GBM cell line as a model. Our findings demonstrate that both peanut and sphere-shaped microparticles effectively decrease U87 cell viability in a dose-dependent manner (61–77% viability with peanuts and 81-27% viability with spheres between 12.5 and 400 μg/ml dosage), while also significantly reducing cell proliferation. We also compare our results with GBM cells to HMC3 cells as a control. This study highlights the therapeutic potential of these microparticle microrobots in reducing key hallmarks of GBM progression and opens up new possibilities for their application in precision cancer therapies using novel microrobot-based strategies.

Authors

Institutions

Publication Details

Journal
Cellular and Molecular Bioengineering
Published
2026-10-06
DOI
https://doi.org/10.1007/s12195-026-00941-x
Primary Topic
Micro and Nano Robotics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Shape Matters: Drug-free Glioblastoma Targeting with Magnetic Microparticles

Wance J. J. Firdaus, Sambeeta Das, David P. Rivas
Cellular and Molecular Bioengineering
Micro and Nano Robotics
article

Shape Matters: Drug-free Glioblastoma Targeting with Magnetic Microparticles

Wance J. J. Firdaus, Sambeeta Das, David P. Rivas
article en

Abstract

Abstract Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options and poor survival rates. In this study, we investigate the potential of peanut-shaped and sphere-shaped microparticles as microrobots for targeted GBM therapy, specifically using the U87 GBM cell line as a model. Our findings demonstrate that both peanut and sphere-shaped microparticles effectively decrease U87 cell viability in a dose-dependent manner (61–77% viability with peanuts and 81-27% viability with spheres between 12.5 and 400 μg/ml dosage), while also significantly reducing cell proliferation. We also compare our results with GBM cells to HMC3 cells as a control. This study highlights the therapeutic potential of these microparticle microrobots in reducing key hallmarks of GBM progression and opens up new possibilities for their application in precision cancer therapies using novel microrobot-based strategies.

Cellular and Molecular Bioengineering
University of Delaware (US)
Openalex Percentile: Top 21%
Micro and Nano Robotics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Shape Matters: Drug-free Glioblastoma Targeting with Magnetic Microparticles — Wance J. J. Firdaus, Sambeeta Das, et al. · Cellular and Molecular Bioengineering (2026) | TGRS Research Map | TGRS